Escitalopram Oxalate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

93 API Suppliers, 33 USDMF, 18 CEP/COS, 10 JDMF, 17 EU WC, 31 KDMF, 19 NDC API, 39 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

24 Intermediate Suppliers

24 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

562 FDF Dossiers, 84 FDA Orange Book, 219 Europe, 55 Canada, 86 Australia, 41 South Africa, 77 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE, SOLUTION;ORAL - EQ 5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 3 Rochem International Inc, 18 SPI Pharma, 7 DKSH, 2 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 21 BASF, 1 CD Formulation, 2 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 20 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 27 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

69 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 34 Thickeners and Stabilizers, 31 Direct Compression, 28 Solubilizers, 25 Granulation, 24 Controlled & Modified Release, 24 Parenteral, 23 Film Formers & Plasticizers, 23 Disintegrants & Superdisintegrants, 20 Taste Masking, 19 Topical, 19 Chewable & Orodispersible Aids, 13 Lubricants & Glidants, 13 Co-Processed Excipients, 12 Rheology Modifiers, 8 Emulsifying Agents, 6 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

9 News #PharmaBuzz

9 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 73 Regulatory FDF Prices, 6 Annual Reports

MARKET PLACE

16 APIs, 2 FDF Dossiers, 1 Intermediates

PATENTS & EXCLUSIVITIES

4 US Exclusivities, 8 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 4 USP, 5 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21365 / DOSAGE - SOLUTION;ORAL - EQ 5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ESCITALOPRAM OXALATE(UNII: 5U85DBW7LO) (ESCITALOPRAM - UNII:4O4S742ANY)	ESCITALOPRAM	5mg in 5

Inactive Ingredients

Ingredient Name	Actavis Pharma, Inc.
CITRIC ACID MONOHYDRATE(2968PHW8QP)
GLYCERIN(PDC6A3C0OX)
MALIC ACID(817L1N4CKP)
METHYLPARABEN(A2I8C7HI9T)
PEPPERMINT(V95R5KMY2B)
PROPYLENE GLYCOL(6DC9Q167V3)
PROPYLPARABEN(Z8IX2SC1OH)
SODIUM CITRATE(1Q73Q2JULR)
SORBITOL(506T60A25R)
WATER(059QF0KO0R)

Setid 38affda1 D365 4d81 8e9c 50482a27d7fc Applno 21365 Form Solution Oral Dosage Eq 5mg Base 5ml - Drug Product Composition: Escitalopram Oxalate